respectively (Simenew, Bekana, Fikre, & Tilahun, 2011) . Another recent study including slaughterhouse data collected from 345 culled cows showed that 51 had ovarian abnormalities. The percentages of hypoplasia/atrophy, cysts and adhesions were 11.45%, 5.22% and 6.38%, respectively (Mekibib, Desta, & Tesfaye, 2013) . The proportion of cows culled due to ovarian dystrophy is increasing yearly and accounts for most culls (Mekibib et al., 2013; Simenew et al., 2011) .
Amniotic fluid stem cells (AFSCs) have self-renewal capabilities (Karlmark et al., 2005) and can double in a shorter period than MSCs (Chang et al., 2013) . Furthermore, they tend to have low immunogenicity when allografted (De Coppi et al., 2007) . AFSCs have recently been studied extensively in regenerative medicine to treat a variety of damaged tissues and organs, such as muscle (Chang et al., 2013) . Previous studies have shown that AFSCs are easily obtained and have pluripotent characteristics. For this reason, they are the preferred type of stem cell in regenerative medicine research. Studies have shown that they may have the potential to restore ovarian function (Lai et al., 2013) . In addition, mouse AFSCs transplanted into mice with chemotherapy-induced premature ovarian failure partially restored ovarian function (Xiao et al., 2014) .
Studies have shown that post-partum cows readily develop ovarian dystrophy (Wathes, Taylor, Cheng, & Mann, 2003) . In the present experiment, we hypothesized that transplanting AFSCs into cows with ovarian dystrophy would improve or restore ovarian function.
| MATERIALS AND METHODS

| Animal care
All experimental procedures with cows were approved by the Institutional Animal Care and Use Committee of the National Taiwan University (NTU-103-EL-34). The procedures were conducted according to approved guidelines.
| Collection, isolation and culture of bovine amniotic fluid stem cells
Amniotic fluid was collected from the uteri of eight pregnant HolsteinFriesian cows (approximately 3-to 4-month pregnant) at a slaughterhouse. The amniotic fluid was diluted in a 1:1 ratio with Dulbecco's phosphate-buffered saline (DPBS), containing 100 IU/ml penicillin and 100 mg/ml streptomycin, in a sterile centrifuge tube. It was centrifuged at 470 g for 15 min. The concentrated cells were cultured in 5 ml culture medium (1:1 DMEM/M199 containing 10% FBS, 100 IU/ml penicillin and 100 mg/ml streptomycin). The cells were centrifuged at 470 g for 15 min.
The concentrated cells were cultured at 38.5°C in the DMEM/M199 mixture in a 10-cm 2 culture dish, with a density of 5 × 10 3 cells/cm 2 . The culture atmosphere contained 5% CO 2 , and relative humidity was high.
| Induction of adipogenic differentiation
The BAFSCs were cultured to the third passage, and then, the culture medium was substituted with the adipogenic differentiation medium, αMEM, containing 10% FBS, 10 μg/ml insulin (Sigma, i6634), 1 μM dexamethasone (Sigma, d4902), 0.5 mM isobutyl-methylxanthine (Sigma, i5879) and 100 μM indomethacin (Sigma, i7378). The culture medium was replaced every 3 days, and the cells were analysed after 14 days of culture. Accumulated fat droplets were stained using oil red O (Sigma, o9755) and evaluated by microscopic examination (10 × 20).
| Induction of osteogenic differentiation
The BAFSCs were cultured to the third passage; then, the culture medium was substituted with osteogenic induction medium αMEM containing 10% FBS, 0.1 μM dexamethasone, 10 nM glycerol-2-phosphate (Sigma, g9891) and 50 μM ascorbate-2-phosphate (Sigma, a8960). The culture medium was replaced every 3 days and was analysed after 21 days of culture. The induced cells were stained with alizarin red S (ARS; Sigma, a5503); calcium deposits stained black on microscopic examination (10 × 40).
| Induction of chondrogenic differentiation
The BAFSCs were cultured to the third passage; then, the cells were removed using 0.25% trypsin-EDTA and centrifuged at 470 g for 5 min. The supernatant was removed, and 2.5 × 10 5 cells were mixed with 1 ml αMEM containing 1% FBS, 50 nM ascorbate-2-phosphate, 6.25 μg/ml insulin and 10 ng/ml TGF-β1 for chondrogenic induction.
The culture medium was replaced every 3 days and was analysed after 21 days of culture. The cellular suspension was collected, placed in 4% paraformaldehyde and shaken for 24 hr at 4°C. The tissue was embedded in paraffin, sectioned (5 μm thickness) and stained with toluidine blue for microscopic examination (10 × 40).
| Reverse transcription-polymerase chain reaction gene expression analysis
Total RNA was isolated from the BAFSCs using TRIzol (Invitrogen Corp., USA) and treated with deoxyribonuclease to remove contaminating genomic DNA. The RNA concentration was determined by absorbance at 260 nm using a spectrophotometer (Thermo Fisher Scientific, USA); then, 2 μg RNA was used in each 20-μl reaction. Each sample served as a template for a one-step reverse transcription-polymerase chain reaction Assays for MSC surface markers (CD34, CD44, CD45, CD73, CD166, β-integrin), a pluripotent surface marker (Oct4) and a GAPDH internal control were conducted using the primers shown in Table 1 . The RT-PCR products were evaluated using 2% agarose gel with ethidium bromide.
| Animal age, reproductive history, milk yield, feeding and management
Taiwan has a subtropical climate ( No oestrus phenomena were detected by the oestrus detection system during the last 6 weeks before treatment (approximately 170 days after the previous delivery). Bilateral ovarian atrophy was confirmed by ultrasonography every week, and the study was continued.
Two groups of four cows each were included in the second labour and third labour of lactating cows. The mean ages at second labour in the control and BAFSC groups were 39.8 and 40.8 months, respectively; the third labour occurred at 54.8 and 55.5 months, respectively.
The average milk yields (305-2X-ME) during the second labour of the control, and BAFSC groups were 7329 and 7296 kg, respectively; yields during the third labour were 7765 and 7795 kg, respectively.
The mean first parturition ages of the second labour in the control and BAFSC groups were 23.5 and 23.3 months, respectively; the mean first parturition ages at third labour were 23.3 and 23.8 months. The mean second parturition ages of the control and BAFSC treatment groups at second labour were 35.8 and 36.2 months, respectively; the mean second parturition ages at third labour were 36.8 and 37.8 months. The mean third parturition ages at third labour were 50.3 and 51.5 months, respectively. The average duration of the empty foetal period in the second labour and third labour in the control group before injection was 174 and 177 days, respectively; the average in the BAFSCs treatment group was 171 and 168 days, respectively (Table 3) .
Experimental cows were fed at the Agriculture Experiment Station,
College of Bioresources and Agriculture, National Taiwan University.
The lactating cows were fed in a barn with a concrete floor, beds, mangers and a shade canopy. The barn was clean, airy and well lit and had fans and intermittent watering facilities. The animals received a total mixed ration of concentrated feed, alfalfa hay, Bermuda hay and corn silage. Mineral salt and water were provided ad libitum.
| Detection of oestrus
The 16 cows were randomly divided into a control (sham injection) group and a BAFSCs injection group of eight cows each. The experimental period lasted 15 weeks; the oestrus cycles of the lactating cows were monitored during weeks 1-6 using Automatic Heat ® (De Laval, USA).
The cows received sham or BAFSC injections during week 7 and were monitored for oestrus from weeks 8-15 (Figure 1 ). If heat was detected, the cow was known to be in oestrus and AI was performed after 8-12 hr.
| Cell transplantation and injection gun
BAFSCs cultured to the third passage were suspended in PBS containing 1% polyvinyl alcohol (PVA). Each ovary was injected with approximately 5.8 × 10 5 cells (50-μl suspension). The control group ovaries received 50 μl of PBS/1% PVA. The cells were administered using an injection gun (Figure 2) . Figure 2a shows a cell injection tool. 
| Semen source and preparation for the breeding experiment
Frozen semen from the same bull was used (Frontier Agriculture Systems, Inc., Taipei, Taiwan); each straw contained 22 million sperm.
After thawing the frozen semen for 30 s at 36-37°C and evaluation of the sperm quality, AI was performed.
| Ultrasonography, blood collection and hormone analysis
Changes in the ovaries were evaluated using a rectal ultrasound (portable ultrasound scanner equipped with a 5.0-MHz linear array transducer; SonoSite, Inc., USA) once per week for 6 weeks.
Subsequently, the BAFSCs were injected and the cows were monitored for 8 weeks following treatment. Blood was collected to analyse the serum progesterone concentration once per week for 6 weeks before BAFSCs injection and for 8 weeks after injection.
Blood samples (10 ml) were obtained from the vena coccygea.
The blood was placed in a 4°C refrigerator for 30 min. The upper serum was then collected by centrifugation for 10 min (3,000 g) and placed in a −80°C freezer. The serum progesterone concentration 
| Statistical analysis
SAS software was used for analysis. The effect of serum progesterone concentrations in the control and treatment groups during experimental weeks 1-15 was analysed. The interaction between the control and treatment groups was analysed using a two-factorial analysis of variance. p < .05 was considered significant.
| RESULTS
| Isolation of amniotic fluid stem cells and differentiation assay
We obtained BAFSCs from cows that were 3-to 4-month pregnant.
After the third passage, we were able to culture full plates of adherent cells in vitro for 6-7 days. The cells had a variety of morphological appearances during culture, including spindle-shaped cells in a fibroblast-like pattern (Figure 3a) . When we placed the BAFSCs in adipogenic medium, fat formed and stained positive using oil red O (Figure 3b ). We also cultured BAFSCs in osteogenic medium to produce calcium deposition and a mature nodular structure, as stained by ARS (Figure 3c ). The BAFSCs exhibited a blue-purple substrate when stained using toluidine blue after culture in cartilage medium for 21 days (Figure 3d ). This confirms that BAFSCs differentiated into adipocytes, osteocytes and chondrocytes.
| BAFSCs mRNA gene expression
Using RT-PCR analysis of gene expression, we found that the BAFSCs expressed β-integrin, CD44, CD73, CD166 and Oct-4; CD45 or CD34
were not expressed (Figure 4 ). It is verified that BAFSCs have the specific gene expression pattern of MSCs (Gao et al., 2014) .
| Animal experiment
| Serum progesterone concentrations
The progesterone concentrations from a single cow in the control and BAFSC treatment groups are presented in Figures 5 and 6 . There was no significant difference in the progesterone concentrations between the control group and the treatment group during weeks 1-9, but the concentration in the BAFSCs group was significantly higher than the control group at week 10 (p < .01). The progesterone concentration in the BAFSCs-treated group was significantly higher than that in the control group (p < .001) at weeks 11-15 (Figure 7) . The results showed that bovine ovarian dystrophy treated with BAFSCs enabled oestrus and subsequent pregnancy by AI, suggesting increased serum progesterone concentration. and 32 days, respectively. At 15 days, there were 7-and 12-mm follicles on the left and right ovaries of the cow that had entered oestrus, respectively. At 25 days, there were 6-and 13-mm follicles on the right ovary. At 22 and 32 days after BAFSCs injection, there were no follicles >5 to 6 mm on the left ovary; however, there were 10-and 11-mm follicles on the right ovary, respectively (Figure 10 ). At 15 and 25 days after treatment of BAFSCs, corpus lutea were detected after AI for 1-6 weeks. At 22 and 32 days after BAFSCs injection, there was no follicle >5 to 6 mm, or corpus luteum, after AI during weeks 12-15.
| Ultrasonography
In addition, at 15 and 25 days after treatment with BAFSCs, two cows were determined to be in heat (ovulation was detected via ultrasonography) after parturition 25 and 28 weeks previously.
| Oestrus rate, pregnancy rate and parturition
In the control group, the automatic heat test did not detect oestrus in any cows during the experimental period. However, oestrus was detected in four cows in the treatment group, at 15, 22, 25 and 32 days after BAFSCs injection, respectively. Therefore, the oestrus rate after
BAFSCs treatment was 50% (4/8). We observed foetuses on ultrasonography approximately 40 days after AI into two cows (oestrus at 15 and at 25 days after treatment). Thus, the pregnancy rate of the treatment group was 25% (2/8). In the BAFSCs treatment group, each had a pregnancy from second labour and third labour, and the pregnancies lasted 38 and 39 weeks, respectively (Figure 11a ,b). BAFSCs may have the ability to alleviate ovarian dystrophy, and a calf can be delivered after the cow enters oestrus and undergoes AI.
| DISCUSSION
Recently, data have shown that many dairy cows are culled due to ovarian hypoplasia/atrophy, cysts and adhesions (Mekibib et al., 2013). Specifically, it is considered abnormal when anestrous continues for more than 50-60 days following parturition (Rhodes, McDougall, Burke, Verkerk, & Macmillan, 2003) . In tropical regions, bovine reproductive characteristics are considered to be decreased when anestrous continues for 150 days after parturition, and the high incidence can cause serious economic losses (Montiel & Ahuja, 2005) .
Among the two groups, four cows had undergone second labour and third labour as lactating cows. The mean ages of the second labour and third labour groups were 40.2 and 55.1 months, and the average ages of the control and BAFSC groups were 47.3 and 48.1 months, respectively. Two groups of lactating cows had empty foetal periods of approximately 130 days, and oestrus was not detected before the trial. Bilateral ovarian atrophy was confirmed weekly by ultrasound, as the cow and herd cycles are quiescent after delivery. Hence, the lactating cows received BAFSCs treatment during the more than 150 days of the empty foetal period. Liu, Huang, Guo, Cheng, and Zou (2012) indicated that human
AFSCs can survive and proliferate in mice with premature ovarian failure; the cells may also restore ovarian function (Lai et al., 2013) .
In addition, AFSCs have anti-inflammatory activity and are capable of repairing damaged tissues and organs (Bollini, Pozzobon, Nobles, Riegler, & Dong, 2011) . In this study, we used weekly ultrasonography to observe ovarian changes. Miyamoto et al. (2006) indicated that the three critical diameters for the measurement of follicular growth using ultrasonography were (i) follicle appearance (4 mm), (ii) follicle growth (9 mm) and (iii) pre-ovulatory follicles (10-20 mm). We saw no follicles on the ovaries of the control group during the experiment. However, we observed follicles in treatment group ovaries. BAFSCs had a verified therapeutic effect on ovarian dystrophy, and the cows' oestrus capabilities were restored.
Progesterone concentrations greater than 1 ng/mL in at least two consecutive oestrus cycles indicate corpus luteum (CL) activity in cows (Crowe, 2008) . The average progesterone concentrations of the control group during weeks 1-15 were less than 1 ng/ml. In accordance with the findings of Sakaguchi (2011) , the ovarian activity of the experimental cows had ceased. During week 7, PBS containing 1% PVA or 1% PVA with BAFSCs was injected. Thus, the cow entered oestrus after BAFSCs treatment and became pregnant after AI. The progesterone concentrations in the treatment group during weeks 9-15 were >1 ng/ml. The high progesterone concentration reflects luteal activity.
Automatic heat detection did not detect oestrus in the control group during the experiment. However, oestrus was detected in four cows in the treatment group. The automatic heat detection signal increased in twice the number of cows in the treatment group as in the control group (data not shown). Out of eight animals only four showed oestrous symptoms; only two, however, apparently ovulated, had CL formation and eventually became pregnant, i.e. treatment success is 25%. Two cows, even though in oestrus, apparently did not ovulate, because as no CL was formed. This result can also be achieved by other treatments, such as OVSYNCH and PRID (Alnimer & Lubbadeh, 2003; Pacala et al., 2010) . For perspective, the results should be compared to other treatment strategies for ovarian dystrophy. BAFSCs might have an effect, but is not better than other treatments.
In conclusion, BAFSCs injection could induce oestrus in HolsteinFriesian cows with bilateral ovarian dystrophy. Therefore, BAFSCs can alleviate ovarian dystrophy and restore fertility in dairy cows. Our results confirm that BAFSCs may cure ovarian anovulation and possibly halt infertility-causing phenomena in dairy cows.
F I G U R E 1 1 Two calves were delivered after injection of bovine amniotic fluid stem cells (BAFSCs). One calf was delivered from a cow bred after observation of oestrus, 15 days after BAFSCs injection (a); another calf was delivered from a cow bred 25 days following BAFSCs injection (b). The two cows were pregnant for 38 (a) and 39 weeks (b), respectively (a) (b)
